Related references
Note: Only part of the references are listed.A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
Hyun Yang et al.
JOURNAL OF HEPATOLOGY (2022)
How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
Grace L. H. Wong et al.
JOURNAL OF HEPATOLOGY (2022)
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B
Hye Won Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta-analysis
Aixin Song et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Comparison of Long-Term Clinical Outcomes Between Spontaneous and Therapy-Induced HBsAg Seroclearance
Jonggi Choi et al.
HEPATOLOGY (2021)
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
Grishma Hirode et al.
GASTROENTEROLOGY (2021)
How Do We Determine Whether a Functional Cure for HBV Infection Has Been Achieved?
Terry Cheuk-Fung Yip et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B-Report From the 2019 EASL-AASLD HBV Treatment Endpoints Conference
Markus Cornberg et al.
HEPATOLOGY (2020)
Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Ting Ting Chan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective
Grace Lai-Hung Wong et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)
Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis
Ryan T. Anderson et al.
Clinical Gastroenterology and Hepatology (2020)
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
Yee Hui Yeo et al.
GASTROENTEROLOGY (2019)
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2019)
Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen
Terry Cheuk-Fung Yip et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2018)
The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B
Byung Gyu Kim et al.
LIVER INTERNATIONAL (2018)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B
George V. Papatheodoridis et al.
HEPATOLOGY (2017)
Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
HBV DNA Integration: Molecular Mechanisms and Clinical Implications
Thomas Tu et al.
VIRUSES-BASEL (2017)
Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis
J. C. -T. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2016)
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma
Carlo Saitta et al.
LIVER INTERNATIONAL (2015)
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Gi-Ae Kim et al.
GUT (2014)
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
Jessica Liu et al.
GUT (2014)
How grim is hepatocellular carcinoma?
Elroy P. Weledji et al.
ANNALS OF MEDICINE AND SURGERY (2014)
Meta-analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma
G. L-H Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Goodness-of-fit test for proportional subdistribution hazards model
Bingqing Zhou et al.
STATISTICS IN MEDICINE (2013)
Competing risks regression for clustered data
Bingqing Zhou et al.
BIOSTATISTICS (2012)
Occult HBV infection among Egyptian hepatocellular carcinoma patients
Zeinab K. Hassan et al.
VIROLOGY JOURNAL (2011)
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma
CM Chu
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Share Paper
